Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir?the company's twice-yearly injectable HIV ...

Charlotte, North Carolina--(Newsfile Corp. - February 13, 2025) - (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading and ...

Light AI Inc. ("Light AI" or the "Company") (CBOE CA: ALGO) , a global healthcare technology company focused on developing artificial intelligence health diagnostic and wellness solutions today is ...

Visteon Corporation (NASDAQ: VC) today reported fourth quarter and full-year 2024 financial results. Highlights include: ...

Detailed price information for Iovance Biotherapeutics Inc (IOVA-Q) from The Globe and Mail including charting and trades.

Indian Prime Minister Narendra Modi has heaped praise on Trump in hopes of avoiding the tariffs that the White House has slapped on other countries.

Q4 2024 Earnings Call Transcript February 12, 2025 Rapid7, Inc. misses on earnings expectations. Reported EPS is $0.48 EPS, ...

President Donald Trump has had one of the most active first months in office of any U.S. president. Since Trump’s inauguration, Connecticut Attorney General William Tong has been active in challenging ...

for a decision on marketing authorization for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the management of fibromyalgia.